MARINUS PHARMACEUTICALS, INC. Annual Return On Assets in % from 2015 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Marinus Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from 2015 to 2023.
  • Marinus Pharmaceuticals, Inc. Return On Assets for the quarter ending September 30, 2024 was -122 %, a 103% decline year-over-year.
  • Marinus Pharmaceuticals, Inc. annual Return On Assets for 2023 was -70.7 %, a 520% decline from 2022.
  • Marinus Pharmaceuticals, Inc. annual Return On Assets for 2022 was -11.4 %, a 84% increase from 2021.
  • Marinus Pharmaceuticals, Inc. annual Return On Assets for 2021 was -71.3 %, a 18.3% decline from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -70.7 -59.3 -520% Jan 1, 2023 Dec 31, 2023
2022 -11.4 +59.8 +84% Jan 1, 2022 Dec 31, 2022
2021 -71.3 -11 -18.3% Jan 1, 2021 Dec 31, 2021
2020 -60.3 +19.6 +24.5% Jan 1, 2020 Dec 31, 2020
2019 -79.8 -13.4 -20.1% Jan 1, 2019 Dec 31, 2019
2018 -66.5 -23.1 -53.2% Jan 1, 2018 Dec 31, 2018
2017 -43.4 +24.4 +36% Jan 1, 2017 Dec 31, 2017
2016 -67.8 -13.7 -25.3% Jan 1, 2016 Dec 31, 2016
2015 -54.1 Jan 1, 2015 Dec 31, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.